JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheramy, A.
Right arrow Articles by Glowinski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheramy, A.
Right arrow Articles by Glowinski, J.

Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum

A Cheramy, G Godeheu, M L'Hirondel and J Glowinski

INSERM U114, College de France, Paris, France.

In the presence of magnesium, although ineffective alone, N-methyl-D- aspartate (NMDA, 10(-3) M plus glycine 10(-6) M) stimulated the release of [3H]-dopamine ([3H]-DA) continuously synthesized from [3H]-tyrosine when applied with ACh, the amplitude of the NMDA response being dependent on the ACh concentration. Experiments performed with nicotine, oxotremorine and the antagonists hexamethonium and atropine indicated that both muscarinic and nicotinic receptors are involved in the permissive effect of ACh on the NMDA response. Data obtained in the absence of magnesium or with increasing concentrations of magnesium revealed that the permissive effect of ACh on the NMDA-evoked release of [3H]-DA results from removal of the magnesium block of NMDA receptors. The NMDA-evoked release of [3H]-DA observed in the presence of ACh, nicotine or oxotremorine (10(-3) M) was blocked by either of the protein kinase C inhibitors staurosporine (10(-8) M) and chelerythrine (5 x 10(-7) M). However, these drugs were without effect on responses induced by ACh, nicotine or oxotremorine alone and by NMDA (10(-3) M, in the absence of magnesium). Supporting further the involvement of a protein kinase C activation in the permissive effects of ACh or the cholinergic agonists, NMDA (10(-3) M) stimulated the release of [3H]-DA in the presence of both magnesium and phorbol 12- myristate 13-acetate (10(-6) M) or 1 -oleoyl-2-acetyl-glycerol (10(-4) M), and the NMDA response was markedly potentiated by ionomycin (10(-7) M) used at a concentration that stimulated [3H]-DA release to about the same degree as ACh (10(-4) M). Therefore, besides their depolarizing action, ACh, nicotine and oxotremorine could eliminate the magnesium block of NMDA receptors by activation of protein kinase C.

Volume 276, Issue 2, pp. 616-625, 02/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
J. Y.-L. Lin and J. Lipski
Dopaminergic Substantia Nigra Neurons Express Functional NMDA Receptors in Postnatal Rats
J Neurophysiol, March 1, 2001; 85(3): 1336 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Kaiser and S. Wonnacott
alpha -Bungarotoxin-Sensitive Nicotinic Receptors Indirectly Modulate [3H]Dopamine Release in Rat Striatal Slices via Glutamate Release
Mol. Pharmacol., August 1, 2000; 58(2): 312 - 318.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. Araque, R. P. Sanzgiri, V. Parpura, and P. G. Haydon
Calcium Elevation in Astrocytes Causes an NMDA Receptor-Dependent Increase in the Frequency of Miniature Synaptic Currents in Cultured Hippocampal Neurons
J. Neurosci., September 1, 1998; 18(17): 6822 - 6829.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.